News
Resources
Blog
Sites
The important role of antivirals in the fight against COVID-19
By Richard Moscicki, M.D. | October 6, 2021
Throughout the COVID-19 pandemic, public health officials have focused their response into four main areas: 1) rapid and accurate testing: 2) contact tracing systems to monitor outbreaks; 3)...
Read More
PhRMA awards $150,000 to community-based projects aimed at tackling inequities in access to COVID-19 testing, vaccines and therapeutics
By Jackie McRae | September 21, 2021
The COVID-19 pandemic has widened health disparities, including the gap in average life expectancy and outcomes for many chronic diseases. These inequities in health status and outcomes among...
Read More
A year and a half later: The biopharmaceutical industry remains committed to beating COVID-19
By Joseph Havey | September 8, 2021
Since the start of the pandemic, America’s biopharmaceutical companies have worked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. Already, we’ve...
Read More
Recognizing National Immunization Awareness Month
By Richard Moscicki, M.D. | August 31, 2021
Vaccines have played a critical role in reducing the spread of, and in some cases, eliminating the threat of many devastating infectious diseases. They are often cited as second only to clean...
Read More
Driving further innovation is critical to global vaccine equity
By Megan Van Etten | August 24, 2021
The following is part of a series of Catalyst posts detailing each of the five strategies to advance COVID-19 global vaccine equity – which rely on and benefit from a strong innovation ecosystem.
Read More
Supporting country readiness to boost global vaccine access
By Megan Van Etten | August 12, 2021
The following is part of a series of posts detailing each of the five strategies to advance global COVID-19 vaccine equity – which rely on and benefit from a strong intellectual property ecosystem.
Read More
Ensuring global vaccine equity requires eliminating trade and regulatory barriers
By Megan Van Etten | August 5, 2021
The following is part of a series of Catalyst posts detailing each of the five strategies to advance COVID-19 global vaccine equity – which rely on and benefit from a strong innovation ecosystem.
Read More
Setting the record straight: Addressing common misconceptions about the COVID-19 vaccine
By Mike Ybarra | August 4, 2021
Bolstered by incredible progress in the fight against COVID-19, the biopharmaceutical industry continues to work around the clock to research, develop and manufacture vaccines and therapeutics to...
Read More
Increasing global access to vaccines by optimizing production
By Megan Van Etten | July 29, 2021
The following is part of a series of posts detailing each of the five strategies to advance global COVID-19 vaccine equity – which rely on and benefit from a strong intellectual property ecosystem.
Read More
Guest post: Retired medics return to the field to take on vaccine delivery and disaster relief
By Guest Contributor | July 23, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
